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Abstract
The French scientist Charles Benjamin Rouget identified the pericyte nearly 140 years ago. Since that time the role
of the pericyte in vascular function has been difficult to elucidate. It was not until the development of techniques
to isolate and culture pericytes that scientists have begun to understand the true impact of this unique cell in the
maintenance of tissue homeostasis. In the brain the pericyte is an integral cellular component of the blood-brain
barrier and, together with other cells of the neurovascular unit (endothelial cells, astrocytes and neurons) the
pericyte makes fine-tuned regulatory adjustments and adaptations to promote tissue survival. These regulatory
changes involve trans-cellular communication networks between cells. In this review we consider evidence for cell-
to-cell crosstalk between pericytes and astrocytes during development and in adult brain.
Review
Introduction
The blood-brain barrier (BBB) regulates the passage of
nutrients, essential components, proteins, chemical sub-
stances and microscopic organisms between the blood-
stream and the parenchymal tissue. The anatomical
constituents of the BBB are the endothelial cells (EC),
pericytes, and basal lamina (matrix proteins) that with
astrocytes, neurons, and possibly other glial cells, com-
prise the neurovascular unit [1]. Together, the cells of
the neurovascular unit adapt to environmental changes
and make fine-tuned regulatory decisions that maintain
homeostasis and promote tissue survival [1-4]. Nowhere
is such tight regulation more important than in the
brain where bioenergetic and metabolic homeostasis is
integral for neuronal survival [1,2]. Dysregulation at the
neurovascular level is linked to many common human
CNS pathologies, making the unit a potential target for
therapeutic intervention [1-4].
The role of the CNS pericyte in the neurovascular unit
is still unclear although with improved culturing techni-
ques and the use of genetically engineered animals it
has become increasingly clear that pericytes are integral
to BBB function [3,4]. It is known that pericytes are
highly complex regulatory cells that communicate with
ECs and other cells of the neurovascular unit such as
neurons by direct physical contact and through auto-
crine and paracrine signaling pathways [3-9]. However,
while there is abundant indirect evidence there is little
direct evidence of pericyte-astrocyte communication. In
this review we will summarize what is known about
pericyte-astrocyte transcellular communication. We will
discuss vascular development, BBB function and regula-
tion of the neurovascular unit. The potential role of
pericyte-astrocyte crosstalk in development of disease
pathology will also be covered.
1. Pericytes
Pericytes were described over 100 years ago in 1873 by
the French scientist Charles-Marie Benjamin Rouget and
dubbed the Rouget cell [10]. The Rouget cell was
renamed in the early 1900s to reflect its anatomical
location with in the microvasculature abluminal to the
EC and luminal to parenchymal cells (reviewed in [11]).
In the brain, pericytes are located in pre-capillary arter-
ioles, capillaries and post capillary venules. They synthe-
size and deposit elements of the basal lamina and are
totally surrounded by this vascular compartment [3-7].
Pericytes are local regulatory cells that are important for
the maintenance of vascular homeostasis and hemosta-
sis, and are a source of adult pluripotent stem cells
[12,13]. Pericytes are important cellular constituents of
the BBB and actively communicate with other cells of
the neurovascular unit such as EC, astrocytes, and
neurons. While the communication networks involving
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pericytes and endothelial cells have been considered in a
number of publications, less is known of the cell-to-cell
communication involving astrocytes.
Since its original discovery there has been much con-
fusion and controversy about the pericyte as reflected by
the numerous conflicting publications and definitions
found in the literature. The pericyte has been referred
to as: a) A contractile cell that surrounds the capillary
in a tunic-like fashion [10]. b) A branching contractile
cell on the abluminal wall of a capillary. c) A peculiar
elongated, contractile cell wrapped around pre-capillary
arterioles ‘outside’ the basement membrane [14].
d) A relatively undifferentiated connective tissue cell in
the capillaries or other small blood vessels also called
the adventitial cell [15]. e) A smooth muscle/pericyte or
smooth muscle cell of the capillaries [16,17]. f) A broad
flat cell with slender projections that wraps around the
capillaries [17]. g) A mesenchymal stem-like cell, asso-
ciated with the walls of small blood vessels. As a rela-
tively undifferentiated cell, it serves to support these
vessels, but it can differentiate into a fibroblast, smooth
muscle cell, or macrophage as well other cell popula-
tions if required [3,5-7,12,13,18,19]. h) A pluripotent or
pericyte progenitor cell [13].
In the mature CNS capillary, the pericyte is located
between the EC and parenchymal astrocytes and neu-
rons and is surrounded by the basal lamina [3-7]. Peri-
cytes have a prominent round nucleus that clearly
differs in shape from the elongated cigar shaped nucleus
of the EC. The pericyte extends long processes that
extend over the vessel wall. The morphological pattern
of projections appears to be somewhat heterogeneous
[13]. Pericyte projections can extend around the capil-
lary as originally described by Rouget [10]. The classic
wrapping pattern is also somewhat heterogeneous. The
most common association of the pericyte with the capil-
lary is one in which the pericyte processes are large and
broad and span a continuous surface of the vessel.
Alternatively these processes may form finger-like pro-
jections that are more confined and ensheath a more
finite portion of the vessel surface. A third pattern of
pericyte orientation in the microvessel involves a retrac-
tion of projections with protrusion of the cells away
from the capillaries this represents a migrating pericyte
[20]. Pericytes may also extend along the axis of the
capillary. It is unclear whether morphological differences
in pericyte coverage represent changes in pericyte func-
tion. It is clear however that pericytes can migrate away
from the capillary surface during angiogenesis, in
response to stress stimuli [20-24] and possibly under
other conditions [13]. In normal capillaries the wrapping
pattern predominates but under pathological conditions
the migrating patterns increase [24] and are associated
with upregulation of cell surface proteases [20,21,25].
The CNS pericyte is surrounded by the basal lamina on
all sides. During development and during angiogenesis
the pericyte, assisted by nearby astrocytes discussed
below, deposits basal lamina components [3,4,7,13,25-32].
Even extended pericyte projections, observed using elec-
tron microscopy, have a thin layer of basal lamina. The
basal lamina has been shown to become thicker or thin-
ner in response to stress stimuli [24,33-36]. Changes in
the basal lamina can be directly associated with pericyte
expression of proteases [20,24,25,37-41] and ultimate
migration from its vascular location [20,33,34,42].
The intact basal lamina may provide anchoring and
structural integrity to the capillary but it may also be
involved in regulation of pericyte function and differen-
tiation. It seems intuitive that there must be a reason
why the pericyte is surrounded by laminal proteins.
Αvb8 integrin is important in neurovascular cell adhe-
sion [27,43]. Pericytes encased in the basal lamina or
exposed to laminal proteins do not usually differentiate
(Dore-Duffy, unpublished observations). Thus migration
through the basal lamina is necessary before pericytes
can function in their stem cell capacity [13]. Regulation
at the level of the basal lamina may also be integral to
vascular adaptability to an ever-changing environment
and to pericyte signaling mechanisms [24].
In its pericapillary location, the pericyte may signal
nearby ECs [3,4,13,40,44,45], astrocytes [46,47],
neurons, smooth muscle cells and perhaps other peri-
cytes [13]. Pericyte-EC contacts include peg and socket
arrangements [8,48] and gap junctions [49-52]. Gap
junctions allow pericytes to communicate with ECs
through the exchange of ions and small molecules.
Peg-and-socket contacts enable pericytes to penetrate
through the basal lamina and make contact with other
cells and nearby vessels [8,48,53]. Junction complexes
including adhesion plaques also support transmission
of contractile forces from pericytes to other cells. Peri-
cyte gap junctions contain N-cadherin, a variety of
adhesion molecules, b-catenin, extracellular matrix
(ECM) molecules such as fibronectin, and a number of
integrins [50,51]. Thus, pericytes are involved in highly
complex signaling cascades that enable this cell to
respond to changes in the microenvironment. However,
it is unclear whether gap junctions and peg and socket
contacts are naturally present or whether they are
initiated during changes in functional activity. For
example, it is known that pericytes interdigitate with
ECs during the early phases of angiogenesis and with
neurons during the maturation of newly-formed vessels
[54]. These sites of communication are altered under
pathological conditions. During cerebral edema or dia-
betes, gap junctions are substantially decreased or dis-
rupted in retinal pericytes [54-57]. Diabetes-induced
changes in gap junctions may be regulated by high
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glucose [56-58]. Pericyte-EC communication via gap
junctions is fundamental to the adaptive responses to
compromised bioenergetic homeostasis [58]. Crosstalk
between ECs, pericytes, as well as astrocytes is involved
in regulation of insulin transport [47]. Pericyte/EC
crosstalk is also integral to physiological angiogenesis
[59], and is likely to be important in adaptation to
hypoxic injury and focal capillary contractility.
2. Pericytes and astrocytes during vasculogenesis and
angiogenesis
Vasculogenesis is the formation of new blood-vessels by
differentiation of vascular precursor cells during devel-
opment. During retinal development, a role for astro-
cyte-pericyte communication has been established.
Retinal vascularization begins in the inner retinal layer
and sprouts radially from the optic nerve to reach the
periphery of the retina [60]. Subsequently, retinal vessels
sprout into the deep retinal layer to vascularize three
parallel nerve fiber layers and two plexiform layers.
Experiments using retinal models have tested the
hypothesis that astrocytes and pericytes influence this
process by affecting the composition of the extracellular
matrix. Fibronectin, but not laminin, is expressed in
zones of vasculogenesis immediately prior to vessel for-
mation. At this time astrocytes and pericytes spread into
the tissue and may be involved in the initiation of vascu-
logenesis. In fact, it is unclear whether platelet-derived
growth factor receptors PDGFbR+/PDGFaR+ pericytes
and/or PDGFaR+ immature astrocytes are the regulat-
ing cell type [60]. Increased amounts of fibronectin
mRNA suggest that fibronectin is synthesized by cells
within this same region. Pericytes are known to synthe-
size most extracellular matrix protein components [61].
Differentiation of endothelial cells is correlated with the
appearance of pericytes in the vessel wall and laminin in
the vascular basement membrane. Astrocyte-conditioned
medium stimulates fibronectin expression by both pri-
mary endothelial cells and pericytes [62]. Astrocyte-
induced pericyte synthesis of fibronectin and perhaps
laminin is an essential step in the initiation of retinal
vasculogenesis [63]. It is, however, unclear whether a
similar mechanism functions in the brain.
Vascularization in the brain during development is
derived from a preformed perineural vascular plexus
and occurs almost exclusively through sprouting angio-
genesis that starts at embryonic day 9 in vertebrates
[63]. Angiogenesis is the formation of new vessels from
existing vessels. Sprouting angiogenesis is an invasive
process that involves proteolytic activities required for
degradation of the basal lamina, with pericyte and
endothelial migration through tissue matrix [63]. During
vessel formation, the recruitment of pericytes and astro-
cytes to newly-forming vascular tubes is closely asso-
ciated with the formation of tight junctions. At P4,
invading vessels are in direct contact with pericytes, but
not with astrocytes. With the progression of develop-
ment, foot processes of astrocytes are gathered around
retinal vessels and the maturation of tight junction ZO-
1 in endothelial cells is more clearly defined [64]. Tight
junctions can be formed with contact from pericytes
without the ensheathment of the astrocytic foot pro-
cesses. From in vitro studies it is clear that pericytes
induce synthesis of both occludin and claudin through
the release of angiopoetin-1 [65]. Thus tight junction
formation in the BBB could be developed, in part, by
cellular interactions between EC and pericytes followed
by astrocytes (as reviewed in [66]). The expression of
ZO-1 is augmented by astrocytes [67]. Moreover, ZO-1
as well as occludin or claudin together may be biological
indicators of barrier maturation [67]. The role of the
pericyte in BBB function will be discussed below.
Studies using glial fibrillary acidic protein (GFAP)-
knockout mice (GFAP-/-) indicate that, although astro-
cyte foot interactions with the microvasculature are
missing, neovascularization and the formation of tight
junctions as well as other CNS morphology appears to
be natural [68-70]. Astrocyte neuronal interactions are
disrupted [70]. These data suggest that astrocyte interac-
tion with the capillaries or neurons is not essential for
tight junction formation. Of interest is that GFAP-/-
mice are prone to hemorrhagic injury [71]. Similar
observations were observed by McCarthy and colleagues
[44] in studies using animals lacking alphav integrins. In
contrast, administration of the gliotoxin 6-aminonicoti-
namide (6-AN) to chick embryos during both early and
late embryonic development showed a good correlation
between perivascular glial depletion and BBB impair-
ment suggesting that astroglia do in fact play a role in
BBB prenatal differentiation and must in some way
contribute to vascular function [72]. Taken together
the results suggest that, while astrocyte formation of
end-feet is not essential for tight junction formation,
astrocytes are an important component contributing to
normal vessel structural integrity. These results may
also indicate that pericytes or other CNS cellular com-
ponents can compensate for the lack of direct astrocyte
signaling.
Using in vitro model systems to study vasculogenesis,
scientists have learned that both pericytes and astrocytes
are involved in formation of capillary structures. Both
cell types form endothelial connections with newly
forming vessels (Figure 1) realigning themselves accord-
ing to the same arrangement seen in vivo. Pericytes in
co-culture associate with EC more rapidly than astro-
cytes. In multi-cellular systems involving pericytes,
astrocytes, and EC newly forming tubes have the three
dimensional structure of a vessel and exhibit both a
lumen and tight junctions. Tube formation in triple
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cultures is more rapid than that observed in EC/pericyte
or EC/astrocyte, co-cultures. The triple co-culture of
pericytes and astrocytes with ECs is thought by most
investigators to represent a better model system to
study the BBB [73-76]. This may be in part due to the
role of agrin, aquaporin 4, and astrocyte polarity in the
BBB [77].
The process of vasculogenesis and differentiation is a
complex system that involves crosstalk between numer-
ous cells and is regulated by a number of signaling
pathways.
Cell surface proteases expressed on both EC and peri-
cytes exert additional subtle functions in sprouting
angiogenesis. These functions involve membrane type-1
matrix metalloproteinase (MT1-MMP), other MMPs,
and ADAMs (a disintegrin and metalloproteinase
domain) [78]. Proteases modulate the balance between
pro- and anti-angiogenic factors by activation of growth
factors and chemokines, shedding of chemokines and
cytokines from membrane-bound precursors [78], and
generation of (matrix) protein fragments that inhibit or
activate angiogenesis. Furthermore, they participate in
the recruitment of leukocytes and progenitor cells,
which contribute to the initiation and progression of
angiogenesis. Pericytes are involved in the initiation as
well as termination of angiogenesis (as reviewed in [59]).
At the initiation of angiogenesis, pericytes are involved
in induction of endothelial activation accompanied by
augmentation of a variety of proteases [40], adhesion
molecules and proteoglycans [79]. Astrocyte expression
of tumor necrosis factor converting enzyme (TACE/
ADAM-17) may facilitate pericyte PDGFbR signaling
mechanisms [80]. Alternatively, at maturation the
recruitment of pericytes to the newly-formed endothelial
tubes is accompanied by silencing of MMP activities
[81]. Recruitment to the newly-formed vessel with ter-
mination of angiogenesis involves PDGFb [82] as well as
transforming growth factor beta (TGFb) [83]. PDGFb is
thought to be essential for the retention of pericytes in
the newly-formed vessels [84,85]. Ablation of PDGFb
results in an embryonic lethal mutation associated with
multiple vascular abnormalities [82,86,87].
3. Pericytes, astrocytes and BBB function
3.1 Contractility
The concept that pericytes regulate blood flow at the
capillary level was originally proposed by Steinach and
Kahn in 1903 [88] and Ni in 1922 [89]. Both scientific
groups studied the effects of electrical stimulation or
exposure to toxic stimuli on capillary diameter. Doré
reviewed this area in 1923 [11]. As stated by Doré, [11]:
“Until a few years ago the capillaries were regarded as
elastic tubes undergoing passive distension in accor-
dance with the general blood pressure, the state of con-
traction or dilatation of the supplying arterioles, and the
nutrition of the vascular walls”. The concepts put for-
ward in this 1923 review are on target with exciting
more-recently published data [90-92].
Figure 1 Induction of angiogenesis in triple co-cultures of ECs, pericytes and astrocytes. Primary cells were co-cultured at a ratio of one
pericyte to five ECs and to five astrocytes. Cultures were exposed to hypoxia (10%) to induce angiogenesis (A). Tube formation in triple cultures
involved crosstalk between astrocytes and pericytes. White arrows point to pericytes and black arrows point to astrocytes. Photograph was taken
using phase contrast at 10×. In (B) we show a close up of an astrocyte making contact with both elongating EC and pericytes. The black arrows
point to astrocyte contacts with an elongating EC (left) and one of the two contacts made with a pericyte (right). Pericytes have fewer
projections and are more spread out than the astrocytes.
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CNS pericytes have receptors for a large number of
vasoactive signaling molecules [3,93-95] suggesting that
they have the capacity to be involved in cerebrovascular
autoregulation. Expression of alpha muscle actin
(aSMA) and the intermediate filament desmin, two pro-
teins found in smooth muscle cells, as well as their
adherence to the endovascular cells make them potential
candidates for the regulation of capillary diameter and
focal capillary blood flow [3,8,89,91,96-99]. Electrical sti-
mulation of retinal and cerebellar pericytes is reported
to evoke a localized capillary constriction [91,100]. ATP
in the retina or noradrenaline in the cerebellum also
results in constriction of capillaries by pericytes. Gluta-
mate reverses the constriction produced by noradrena-
line [100].
Following simulated ischemia and traumatic brain
injury (TBI), capillary pericytes are induced to express
aSMA and upregulation of pericyte aSMA is correlated
with a focal decrease in capillary diameter [100]. Upregu-
lation of muscle actin was mediated by endothelin-1.
Other investigators have shown that capillary contraction
can be directly linked to metabolic need [101,102]. Expo-
sure to substances that increase pericyte calcium level
induces vessel contraction with a concomitant decrease
in the capillary lumen diameter [101-103]. The contractile
response appears to involve a cascade of events resulting
in the inhibition of Na+/Ca2+ exchangers on the EC
[103]. Hypoxia, which closes gap junctions, switches the
effect of lactate from contraction to relaxation. Thus,
pericyte function may be linked with local vascular adap-
tation to changes in bioenergetic requirements and is
intimately linked to astrocyte function.
The calcium-dependent transcription factor NFATc3
is a member of the nuclear factor of activated T cells
(NFAT)-family of transcription factors. NFATc3 is criti-
cal for embryonic vascular development and differentia-
tion. Filosa and colleagues investigated the role of
glutamate in control of NFATc3 regulation in pericytes
[104]. Coronal cortical slices from neonatal rats were
subjected to electrical field stimulation or were treated
with glutamate receptor agonist (+/-)-1-aminocyclopen-
tane-trans-1,3-dicarboxylic acid (t-ACPD). Electrical
field stimulation induced NFATc3 nuclear accumulation
in pericytes and astrocytes. The response in pericytes
was dependent on metabotropic glutamate receptor
(mGluR) activation. NFATc3 nuclear accumulation in
pericytes was prevented when astrocytic function was
abolished with the gliotoxin L-alpha-aminoadipate.
Results suggest that astrocyte glutamate, via mGluR
activation, may regulate gene transcription in pluripo-
tent vascular pericytes [104].
3.2 BBB Permeability
It has been known for decades that the CNS tissue
microenvironment provides the cues for BBB induction
and differentiation (as reviewed in [3,7,90,105]). Develop-
ment of the BBB (barrier genesis) is the result of coordi-
nated molecular signaling at the neurovascular interface
[106]. Only recently has the canonical Wnt/beta-catenin
pathway and the Wnt7a/7b growth factors been impli-
cated in CNS angiogenesis and in BBB induction
[86,105-108]. This pathway interacts with other pathways
that are crucial for vascular development such as VEGF.
Wnt/beta-catenin pathways enhance pericyte mesenchy-
mal differentiation in the presence of TGF-beta3, as
demonstrated by increased Sox-9 expression and glycosa-
minoglycan release into the extracellular matrix. In con-
trast, transduction of pericytes with a recombinant
adenovirus encoding dominant-negative T-cell factor-4
blocked Wnt/beta-catenin signaling and inhibited pericyte
differentiation to chondrocytes, leading to reduced Sox-9,
reduced type II collagen expression and reduced glycosa-
minoglycan accumulation [105,107]. These data demon-
strate that TGF-beta3 induces the chondrogenic
differentiation of pericytes by inducing Wnt/beta-catenin
signaling and T-cell factor-induced gene transcription. In
response to injury, the Wnt/beta catenin signaling
pathway is enhanced in proliferating NG2 chondroitin
sulphate proteoglycan positive cells undergoing differen-
tiation to NG2 glia [109]. It is unclear whether induction
of Wnt/beta-catenin signaling in pericytes is responsible
for the regulation of the BBB by augmenting the number
of NG2+ astrocyte subsets.
Pericytes play a key role in vascular remodeling dur-
ing development and in the adult. Considerable insight
into pericyte biology during development has arisen
from studies employing genetically-manipulated mice
with disrupted PDGFb/platelet PDGFbR signaling
[84-87,110]. During development, EC-secreted PDGFb
binds to pericyte PDGFbR receptors located on the
pericyte plasma membrane resulting in dimerization of
the receptor [111]. Pericytes themselves produce
PDGFb and thus may signal in an autocrine fashion
[13]. PDGF stimulates the proliferation, migration, and
recruitment of pericytes to the vascular wall of newly-
formed blood vessels [10,14,15,83-87,112]. PDGFb and
PDGFbR knockout mice have diminished pericyte
numbers and a lack of pericyte coverage [87]. The
mutation is embryonic lethal with abnormal vasculo-
genesis [87,112]. Loss of pericytes also results in loss of
BBB integrity during embryogenesis [113] clearly show-
ing that pericytes are essential to the differentiation of
the BBB during development and have an important
role in regulating the BBB [114]. The exact mechan-
isms are still somewhat unclear as pericytes have been
shown to both induce permeability and to inhibit per-
meability during development [113-115].
PDGFb and PDGFbR interactions are also involved in
pericyte-mediated regulation of vascular function in the
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adult brain and have a pivotal role in the regulation of
the cerebral microcirculation. However, the functional
roles of CNS pericytes in the adult and aging brain are
less well understood. In the adult animal, it is generally
accepted that pericyte association with the microvessel
is essential to vascular integrity and that loss of pericytes
leads to an increase in vascular leakage and altered vas-
cular function. However, loss of pericytes does not
always result in a permanent loss of function and does
not always result in disease. Pericytes migrate naturally
during the early phases of physiological angiogenesis to
make way for growing sprouts [116-119], or in response
to stress or injury [20]. Migration from the microvessels
following TBI for example, is thought to promote survi-
val as pericytes remaining in their vascular location
show signs of degenerative activity [20]. Migration from
the vessel involves upregulation of cell surface proteases
[20]. Newly-forming vessels both in adult angiogenesis
and neovascularization are characterized by increased
leakiness. This is transient under normal circumstances
but is abnormal in conditions such as pathological
angiogenesis. During angiogenesis there is co-migration
of pericytes with EC sprouts [116-120] and concomitant
proliferation of migrated cells before renewed pericyte
coverage and termination of angiogenesis [59]. Pericytes
may also be recruited from the bone marrow in adult
mice and may have a role in initiation as well as termi-
nation of angiogenesis [84,120]. Renewed pericyte cover-
age restores vascular integrity. These observations are
supported by data derived using in vitro models of
angiogenesis [121-123]. Lack of pericyte termination of
angiogenesis alters vascular function and may promote
vascular leakiness in part by structural problems with
tight junctions [113,114]. Pericytes may also be essential
to regulation of transport mechanisms [86,108]. Taken
together it is easy to speculate that loss of pericyte func-
tion may result in the induction of edema and inflam-
mation [3-7,113,114].
Is there a role for astrocytes in maintenance of BBB
function? Certainly the astrocytes provide a structural
barrier that helps promote vascular integrity. As dis-
cussed, microvessels from the GFAP knockout mouse
that have no astrocyte end-feet have a tendency to form
micro-hemorrhages despite the presence of normal tight
junctions [68,69]. The interaction of astrocytes with the
capillary appears to have an ordered structure as seen in
Figure 2a in wild type capillaries. GFAP staining seems
to have a fish net orientation that may assist in promot-
ing vascular integrity. Heterozygous animals display a
very disordered GFAP staining (Figure 2b). Capillaries
from GFAP-/- mice display no staining pattern (Figure 2c).
We have found that, to compensate for the loss of
astrocyte end-feet, pericytes proliferate. Pericyte to EC
ratios are much higher than those observed for wild
type mice and for GFAP+/- heterozygotes (Figure 3;
Table 1). This is in contrast to data by others [84] using
PDGF deficient animals. The presence of astrogliosis
may also alter pericyte function [87].
The integral association of PDGF/PDGFR signaling in
maintenance of pericyte function, makes it easy to spec-
ulate that astrocytes may be able to regulate pericyte
function by the modulation of PDGFb signaling. Con-
trolled synthesis of astrocyte H2O2 alters PDGF signal-
ing and is neuroprotective in conditions of oxidative
stress [124-128]. The expression of truncated PDGFbR
inhibits PDGF signaling [129]. Inhibition is also seen
with upregulation of PDGFaR [130]. Heparan sulphate
controls the diffusion, and thus the availability of
PDGFb [131]. Perlecan, a heparin sulfate proteoglycan,
has been reported to modulate the BBB [132] and is
produced by astrocytes during the stress response [133].
Astrocyte modulation of pericyte function is seen in the
injured retina [60,64].
4. Pericyte-astrocyte communication and disease
Under normal conditions, the pericyte is relatively
quiescent and is essential for vascular stability. Under
conditions of stress or injury, the pericyte undergoes
phenotypic and functional changes that may include
migration, proliferation or differentiation. How these
events that include pericyte reprogramming are coordi-
nated at the molecular level needs to be determined.
However, it is clear that pericyte dysfunction or the loss
of pericytes is likely to play an important role in the
pathogenesis of disease.
Pericyte loss or a reduced pericyte-to-EC ratio may be
achieved through: 1) migration of pericytes from their
microvascular location under pathological or physiologi-
cal conditions, 2) pericyte death, 3) reduced pericyte
turnover or maintenance, and 4) selective alteration of
pericyte recruitment to EC that may be associated with
dysregulation of angiogenesis and abnormal PDGFb sig-
naling. Loss of pericytes with reduced pericyte-to-EC
ratios results in a focal increase in permeability. This
can be normal as seen in the transient decrease in peri-
cyte-to-EC ratios due to migration of pericytes during
endogenous adaptation to chronic mild hypoxia [59,134]
or may be abnormal as observed in a number of patho-
physiological diseases. Migration may also play a patho-
genic role such as that observed in diabetic retinopathy
[135]. Decreased pericyte-to-EC ratios have been
observed following TBI (20) and stroke [136], multiple
sclerosis [137-140], brain tumors [141-143], diabetic
retinopathy [135,144], aging [145,146], and in a variety
of angiopathies [147]. Pericyte loss may also play a role
in Alzheimer’s disease, however; enhanced pericyte cov-
erage of some vessels suggests that increased prolifera-
tion of pericytes is an adaptation to focal loss of
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bioenergetic homeostasis [14,140,148,149]. Pericyte loss
due to cellular degeneration/apoptosis has been shown
in hypertrophic scars, keloids [150,151], early diabetic
retinopathy [150,152], brain tumors [153-156], liver
cancer [157] hyperglycemia [158], and during development
[159]. Premature infants have decreased pericyte coverage
[160]. A decreased pericyte-to-EC ratio also observed
during vascular regression [160].
Increased pericyte coverage may also be an indicator
of vascular dysfunction. Pericyte proliferation has been
associated with development of muscularization during
pulmonary hypertension and is thought to be due to
platelet activating factor [161]. Cochlear pericytes in the
stria vascularis are markedly affected by acoustic trauma
[162]. Levels of the pericyte structural protein, desmin,
substantially increase after noise exposure with a corre-
sponding increase in pericyte coverage of vessels.
Increased expression levels of desmin were associated
with the induction of hypoxia-inducible factor (HIF)-
1alpha and the upregulation of vascular endothelial
growth factor (VEGF). Inhibition of HIF-1alpha activity
decreased VEGF expression levels. Blockade of VEGF
activity with SU1498, a VEGF receptor inhibitor, signifi-
cantly attenuated the expression of desmin in pericytes
and may have altered the adaptive process to acoustic
stress. Increased pericyte-to-EC ratios are also observed
in response to over expression of PDGFb [163]. The
percentage of vessels covered by pericytes is nearly
doubled in myelofibrotic bone marrow [164].
Direct evidence for astrocyte augmentation of pericyte
coverage is lacking. However, indirect observations sug-
gest that astrocytes may help augment pericyte prolifera-
tion through augmentation of PDGFb levels [165] or
release of inflammatory mediators [166] that enhance
gliosis. In patients with glaucoma, enhanced prolifera-
tion is modest but restricted to NG2+ pericytes [167].
Astrocytes and pericytes both express estrogen receptors
[167-169]. Astrocytes have been shown to be a source of
estrogen following neuronal injury due to an upregula-
tion of aromatase [167]. Estrogens attenuate PDGFb sig-
naling in vascular smooth muscle cells [170,171].
On a more subtle level pericyte stem cell activity may
be a target for astrocyte modulation. Pericytes have been
shown to be multipotent adult stem cells in a number of
tissues [12,13]. Primary CNS pericytes are capable of dif-
ferentiating along both the mesenchymal and neural
lineages depending on the culture conditions [[12], as
reviewed [13]]. In the absence of serum in the presence
Figure 2 Capillaries [2-6 micron diameter determined by Image J software] were isolated from wild type C57BL/6 mice (A), GFAP -/+
mice (B), and GFAP -/- mice (C) (Jackson Laboratory). Freshly isolated capillaries were allowed to adhere to coverslips fixed and stained for
the expression of GFAP (Santa Cruz Biotechnology Inc). Capillaries were visualized on a Leitz fluorescent microscope at 40× and 100×.
Figure 3 Pericyte-endothelial cell ratios were determined by isolation of capillaries [2-4 micron diameter determined by Image
J software] from wild type B6 mice (A); heterozygous GFAP -/+ mice (B) and knockout GFAP -/- mice (C). Freshly isolated capillaries were
stained with the fluorescent nuclear dye 4’,6-diamidino-2-phenylindole [DAPI]. Round nuclei (pericytes) and elongated nuclei (EC) were counted.
Numbers are shown in Table 1. Arrows point to round pericyte nuclei.
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of basic fibroblast growth factor (bFGF) cultured adult
pericytes form immature NG2+ astrocytes/radial glial
cells, NG2+ oligodendrocyte progenitor-like cells and
neurons [12]. Thus in response to injury pericytes may
undergo neurogenesis. Astrocyte-generated signaling
molecules have been shown to augment neurogenesis
and differentiation of oligodendrocyte progenitor cells
(OPC) [172]. Radial glial cells also retain neurogenic
potential [173,174]. During injury responses in the
kindled animal, astrocyte activation and induction of
neurogenesis is due in part to augmentation of nestin
expression in pericytes [175,176]. Following TBI, Wnt/
beta-catenin signaling occurs in quiescent NG2 progeni-
tors in the cortex, in subcallosal zone (SCZ) progenitors,
and in subependymal cells surrounding the central canal.
Initially after TBI, beta-catenin signaling was predomi-
nantly increased in a subset of NG2+ progenitors in the
cortex [110]. One week following injury, the majority of
beta-catenin signaling appeared in reactive astrocytes but
not other glial cells. Interestingly, cells with beta-catenin
signaling were not generated following spinal cord injury.
This suggests that although augmentation of pericyte
generated stem cell activity and differentiation may be
essential to tissue plasticity in adult animals responses
may be tissue specific. Further, differentiations within
microvascular locations, as well as other abnormal
pericyte responses to injury, are likely to be highly
deleterious.
5. Pericytes here and now
After its identification by Rouget in the late 1800s, rela-
tively little was published about the pericyte until 1902
when the presence of this intriguing cell was confirmed
[11]. The development of tissue culture techniques, as well
as genetically-manipulated transgenic models in which
pericyte coverage is absent or diminished has stimulated
considerable interest and provided invaluable tools needed
to study pericyte biology. However, while genetically-mod-
ified animals can be an important tool some caution
should be used when attributing functional roles from
observations derived in knockout animals. Adaptive
responses to a genetic modification may also confound the
interpretation. One must also consider that the phenotype
is a function both of the planned genetic manipulation
and of potential adaptive responses to the change.
There are a number of examples in the literature that
uniquely illustrated this point [177]. Pericytes are integral
to the regulation of vascular function as shown in PDGFb
knockouts. However, PDGFa knockout is also embryonic
lethal and displays a similar phenotype [178,179], and
together with PDGFb is also integral to postnatal develop-
ment [180]. In the future more targeted manipulations as
well as fate mapping will likely clarify the functional role
of pericytes in many tissues.
Conclusions
In this review we discussed evidence that pericytes and
astrocytes undergo direct cell-to-cell communication.
We also discuss indirect evidence that suggests that
astrocytes and pericytes coordinate BBB function. It is
clear that this communication is needed for the mainte-
nance of vascular function and must be integral to
endogenous adaptation to injury in the adult neurovas-
cular unit. Loss of pericyte function and/or loss of
proper astrocyte contact with the BBB can result in
pericyte dysfunction and development of disease. A bet-
ter understanding of the mechanisms by which pericytes
communicate with other cells and how altered commu-
nication may result in disease pathology is likely to yield
exciting new insights as well as the development of a
new therapeutic target in CNS disorders.
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